1. Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
   Jiacheng Huang et al, 2021, Frontiers in Oncology CrossRef
2. Chemokine CXCL16 Expression Suppresses Migration and Invasiveness and Induces Apoptosis in Breast Cancer Cells
   Yeying Fang et al, 2014, Mediators of Inflammation CrossRef
3. The Role of Chemoattractant Receptors in Shaping the Tumor Microenvironment
   Jiamin Zhou et al, 2014, BioMed Research International CrossRef
4. Synergistic Analysis of Circulating Tumor Cells Reveals Prognostic Signatures in Pilot Study of Treatment-Naïve Metastatic Pancreatic Cancer Patients
   Sarah Owen et al, 2022, Biomedicines CrossRef
5. Neutrophils and Granulocytic MDSC: The Janus God of Cancer Immunotherapy
   Serena Zilio et al, 2016, Vaccines CrossRef
6. The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases
   Jan Korbecki et al, 2021, International Journal of Molecular Sciences CrossRef
7. CXCR6-CXCL16 Axis Promotes Breast Cancer by Inducing Oncogenic Signaling
   Hina Mir et al, 2021, Cancers CrossRef
8. The Microarchitecture of Pancreatic Cancer as Measured by Diffusion-Weighted Magnetic Resonance Imaging Is Altered by T Cells with a Tumor Promoting Th17 Phenotype
   Philipp Mayer et al, 2020, International Journal of Molecular Sciences CrossRef